Pnc Financial Services Group, Inc. Medicinova Inc Transaction History

Pnc Financial Services Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$7.06 - $12.49 $10,590 - $18,735	-1,500 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$7.96 - $13.23 $221,924 - $368,852	-27,880 Reduced 94.89%	1,500 $0
Q1 2018 May 11, 2018	BUY	$6.6 - $13.91 $193,908 - $408,675	29,380 New	29,380 $0

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $106M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.